摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

nonadec-1-en-4-ol | 121342-62-9

中文名称
——
中文别名
——
英文名称
nonadec-1-en-4-ol
英文别名
1-Nonadecen-4-ol
nonadec-1-en-4-ol化学式
CAS
121342-62-9
化学式
C19H38O
mdl
——
分子量
282.51
InChiKey
ZLGVCQXWYKJRPY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    376.7±11.0 °C(Predicted)
  • 密度:
    0.842±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.5
  • 重原子数:
    20
  • 可旋转键数:
    16
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2
    摘要:
    A series of aliphatic side-chain analogues of pseudomycin was synthesized and evaluated during the course of our sidechain SAR effort. We found that several of the pseudomycin side-chain analogues (e.g., 10) exhibited good in vitro activity against all three major fungi responsible for systemic fungal infections. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00424-8
  • 作为产物:
    描述:
    十六醛烯丙基三甲基硅烷四氯化钛 作用下, 以70%的产率得到nonadec-1-en-4-ol
    参考文献:
    名称:
    Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2
    摘要:
    A series of aliphatic side-chain analogues of pseudomycin was synthesized and evaluated during the course of our sidechain SAR effort. We found that several of the pseudomycin side-chain analogues (e.g., 10) exhibited good in vitro activity against all three major fungi responsible for systemic fungal infections. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00424-8
点击查看最新优质反应信息

文献信息

  • Enantioselective Syntheses of Cryptocarya Triacetate, Cryptocaryolone, and Cryptocaryolone Diacetate
    作者:Catherine M. Smith、George A. O'Doherty
    DOI:10.1021/ol0345529
    日期:2003.5.1
    products from Cryptocarya latifolia have been achieved in 13-15 steps from ethyl sorbate. The route relies upon an enantio- and regioselective Sharpless dihydroxylation and a palladium-catalyzed reduction to establish the absolute stereochemistry. The route also relies upon a highly (E)-selective olefin cross-metathesis reaction to form trans-delta-hydroxy-1-enoates. The resulting delta-hydroxy-1-enoates were
    [反应:见正文]来自山茱rypto的三种天然产物的对映选择性合成是从山梨酸乙酯经过13到15步完成的。该路线依赖于对映体和区域选择性的Sharpless二羟基化反应和钯催化的还原反应,以建立绝对的立体化学。该路线还依赖于高度(E)-选择性的烯烃交叉复分解反应以形成反式-δ-羟基-1-烯酸酯。随后将所得的δ-羟基-1-烯酸酯转化为隐乙酸三乙酸酯,隐caryolone和双隐隐caryolone。
  • Methods of using hydroxy-, alkoxy- and benzyloxy-substituted
    申请人:Hoechst-Roussel Pharmaceuticals Incorporated
    公开号:US05145844A1
    公开(公告)日:1992-09-08
    Novel hydroxy-,alkoxy-and benzyloxy-substituted phospholipids, a process for the preparation thereof, and methods for treating pain, phospholipase A.sub.2 mediated inflammation and similar conditions utilizing compounds or compositions thereof are disclosed.
    本发明披露了新型的羟基、烷氧基和苄氧基取代的磷脂类化合物及其制备方法,以及利用这些化合物或组合物治疗疼痛、磷脂酶A2介导的炎症和类似疾病的方法。
  • Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
    申请人:Hoechst-Roussel Pharmaceticals Incorporated
    公开号:US05030733A1
    公开(公告)日:1991-07-09
    Novel hydroxy-, alkoxy- and benzyloxy-substituted phospholipids, a process for the preparation thereof, and methods for treating pain, phospholipase, A.sub.2 mediated inflammation and similar conditions utilizing compounds or compositions thereof are disclosed.
    本发明揭示了新型的含羟基,烷氧基和苄氧基取代的磷脂,其制备方法,以及利用这些化合物或组合物治疗疼痛,磷脂酶A.sub.2介导的炎症和类似情况的方法。
  • Hydroxy-, Alkoxy- and Benzyloxy substituted phospholipids, a process for their preparation and their use as medicaments
    申请人:HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
    公开号:EP0300397A2
    公开(公告)日:1989-01-25
    The present invention relates to novel hydroxy-, alkoxy-­and benzyloxy-substituted phospholipids and a process for the preparation thereof. The compounds of the invention are suitable for treating phospholipase A₂ mediated inflammation conditions and can, therefore, be used as medicaments.
    本发明涉及新型羟基、烷氧基和苄氧基取代磷脂及其制备工艺。本发明的化合物适用于治疗磷脂酶 A₂介导的炎症,因此可用作药物。
  • US5030733A
    申请人:——
    公开号:US5030733A
    公开(公告)日:1991-07-09
查看更多